Is refractory epilepsy preventable? (Q34123660)

31 July 2017

1 reference

title

Is refractory epilepsy preventable? (English)

1 reference

31 July 2017

Catherine Chiron

5

0 references

Martin J Brodie

2

object named as

Martin J Brodie

0 references

author name string

Santiago Arroyo

1

1 reference

31 July 2017

Martin J Brodie

2

1 reference

31 July 2017

Giuliano Avanzini

3

1 reference

31 July 2017

Christoph Baumgartner

4

1 reference

31 July 2017

Olivier Dulac

6

1 reference

31 July 2017

Jacqueline A French

7

1 reference

31 July 2017

José M Serratosa

8

1 reference

31 July 2017

publication date

1 April 2002

1 reference

31 July 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Epilepsia

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

437-444

1 reference

Management of epilepsy in adolescents and adults.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Is the underlying cause of epilepsy a major prognostic factor for recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

The prognosis for control of seizures with medications in patients with MRI evidence for mesial temporal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Clinical aspects and biological bases of drug-resistant epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Prevalence, classification, and severity of epilepsy and epileptic syndromes in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Do seizures beget seizures? An assessment of the clinical evidence in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

The timing of surgical intervention for mesial temporal lobe epilepsy: a plan for a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Molecular neuropathology of human mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

An open, nonrandomized clinical comparative study evaluating the effect of epilepsy on learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

The role of secondary epileptogenesis in human epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Catastrophic epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Seizure frequency and duration of epilepsy are not risk factors for postoperative seizure outcome in patients with hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

The course of untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Neuronal stress and injury in C57/BL mice after systemic kainic acid administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Epilepsy in the developing brain: lessons from the laboratory and clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Surgery for catastrophic localization-related epilepsy in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Vigabatrin as a first-choice drug in the treatment of West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

EEG and clinical predictors of medically intractable childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Predictive factors for success in surgical treatment for partial epilepsy: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

MDR1 gene expression in brain of patients with medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Antiepileptic drug pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Chemical shift imaging spectroscopy and memory function in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Valproate therapy for prevention of posttraumatic seizures: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

A randomized, controlled trial of surgery for temporal-lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Epilepsy surgery in the first three years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Intractable epilepsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Pre- and postoperative neuropsychological profiles in children and adolescents with temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Seizure control and mortality in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Cognitive consequences of two-thirds anterior temporal lobectomy on verbal memory in 144 patients: a three-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Differential effects of left and right anterior temporal lobectomy on verbal learning and memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Pre- and postoperative socioeconomic development of 151 patients with focal epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Surgical and neurological complications in a series of 708 epilepsy surgery procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Early development of intractable epilepsy in children: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Current concepts of cerebral malformation syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.38501.X

10.1046/J.1528-1157.2002.38501.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference